Clinical Trial Update: Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update examining mesenchymal stem cell transplantation for refractory systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Mesenchymal stem cell transplantation (mesenchymal stem cells)

Snippet

Sponsor: Nanjing Medical University | Conditions: Refractory Systemic Lupus Erythematosus | Phase 1, Phase 2 | Status: UNKNOWN